Kowa Company, Ltd.: all 71 studies

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Trial to Investigate the Safety and Effectiveness of the KI-362-US1 (YP2.2VM) Intraocular Lens (IOL) in Adult Participants for Correction of Aphakia Following Cataract ExtractionNot yet recruitingNCT07650201Not applicable
• A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to StatinsRecruitingNCT07634484Phase 4
• A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract SurgeryCompletedNCT05528172Phase 3Results posted
• A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye DiseaseCompletedNCT05403827Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of K-285 Compared With Menthol Gel for the Treatment of Delayed Onset Muscle Soreness (DOMS) in the Lower ExtremityTerminatedNCT04484428Phase 2Results posted
• Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IRCompletedNCT04447820Phase 2Results posted
• Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following DescemetorhexisCompletedNCT04250207Phase 2Results posted
• A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye DiseaseCompletedNCT04084483Phase 2Results posted
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)TerminatedNCT03071692Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal ImpairmentCompletedNCT03011450Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal FunctionCompletedNCT03001817Phase 3Results posted
• Study of Peretinoin for Suppressing Recurrence of HCV-positive HCCCompletedNCT01640808Phase 3Results posted
• Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on PitavastatinCompletedNCT01422382Phase 4Results posted
• Drug-Drug Interaction of Darunavir/Ritonavir on PitavastatinCompletedNCT01422369Phase 4Results posted
• A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected SubjectsCompletedNCT01301066Phase 4Results posted
• Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed DyslipidemiaCompletedNCT01256476Phase 4Results posted
• Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult VolunteersCompletedNCT01178853Phase 4Results posted
• Drug-Drug Interaction of Lopinavir/Ritonavir on PitavastatinCompletedNCT01057433Phase 4Results posted
• Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult VolunteersCompletedNCT01043094Phase 4Results posted
• Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined DyslipidemiaCompletedNCT00344370Phase 3Results posted
• Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk FactorsCompletedNCT00344175Phase 3Results posted
• Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined DyslipidemiaCompletedNCT00330876Phase 3Results posted
• Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined DyslipidemiaCompletedNCT00325780Phase 3Results posted
• Study to Compare the Efficacy and Safety of Pitavastatin and SimvastatinCompletedNCT00309777Phase 3Results posted
• Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined DyslipidemiaCompletedNCT00309751Phase 3Results posted
• Study to Compare the Efficacy and Safety of Pitavastatin and SimvastatinCompletedNCT00309738Phase 3Results posted
• Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly PatientsCompletedNCT00257686Phase 3Results posted
• Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol LevelsCompletedNCT00249249Phase 3Results posted
• A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis.CompletedNCT06525311Phase 1
• Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.CompletedNCT06247735Phase 2
• A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin IntoleranceCompletedNCT05923281Phase 3
• A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)CompletedNCT05826353Phase 3
• A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)CompletedNCT05795699Phase 3
• Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452CompletedNCT05722262Phase 1
• Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver FibrosisCompletedNCT05327127Phase 2
• A Phase III Confirmatory Study of K-237CompletedNCT05056883Phase 3
• A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-CCompletedNCT04998981Phase 3
• Study to Assess the Food Effect of K-877 in Healthy Adult VolunteersCompletedNCT04742218Phase 1
• A Phase III Long Term Study of K-877 Extended Release TabletCompletedNCT04716595Phase 3
• A Phase III Confirmatory Study of K-877 Extended Release TabletCompletedNCT04714151Phase 3
• K-924 Phase III Long Term StudyCompletedNCT04289662Phase 3
• K-924 Phase III Confirmatory StudyCompletedNCT04289649Phase 3
• Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult VolunteersCompletedNCT04237597Phase 1
• A Clinical Pharmacology Study of K-877 Controlled Release TabletCompletedNCT04079530Phase 2
• Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy AdultsCompletedNCT03712241Phase 1
• Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.CompletedNCT03702673Phase 1
• Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100CompletedNCT03505567Not applicable
• A Study to Evaluate the Safety of K-755 in Healthy VolunteersCompletedNCT03414294Phase 1
• A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT03350165Phase 2
• Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult VolunteersCompletedNCT02922465Phase 1
• Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed DyslipidemiaWithdrawnNCT02799758Phase 3
• Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult VolunteersCompletedNCT02719431Phase 1
• Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312CompletedNCT02676830Phase 1
• Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy SubjectsCompletedNCT02676596Phase 1
• Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed DyslipidemiaWithdrawnNCT02670434Phase 3
• A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult VolunteersCompletedNCT02634034Phase 1
• Tofogliflozin GLP-1 Analogue Combination TrialCompletedNCT02537834Phase 4
• Drug-Drug Interaction Study in Healthy Adult VolunteersCompletedNCT02276001Phase 1
• Drug-Drug Interaction Study in Healthy Adult VolunteersCompletedNCT02275988Phase 1
• Drug-Drug Interaction Study in Healthy Adult VolunteersCompletedNCT02275975Phase 1
• Drug-Drug Interaction Study in Healthy Adult VolunteersCompletedNCT02275962Phase 1
• Drug-Drug Interaction Study in Health Adult VolunteersCompletedNCT02273986Phase 1
• An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.TerminatedNCT02089425Phase 3
• A Thorough Corrected QT Interval TrialCompletedNCT02073084Phase 1
• Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult VolunteersCompletedNCT01952548Phase 1
• Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic SyndromeCompletedNCT01595828Phase 1
• A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin TherapyCompletedNCT01169090Phase 2
• A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403CompletedNCT01131091Phase 1
• A Trial of the Safety and Efficacy of K-604 for the Treatment of AtherosclerosisCompletedNCT00851500Phase 2
• Safety and Efficacy of K-134 for the Treatment of Intermittent ClaudicationCompletedNCT00783081Phase 2
• An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine AttackCompletedNCT00330850Phase 3

← Kowa Company, Ltd. overview and focus areas